Übersetzung für "Gynaecomastia" in Deutsch

Gynaecomastia and acne may occur occasionally during Fertavid/ hCG therapy.

In particular, gynaecomastia was added to the list of undesirable effects.

Gynaecomastia and acne may occur occasionally during Puregon/ hCG therapy.

Gynaecomastia is still regarded as a taboo in our society.

Medications - affect metabolic and hormonal pathways causing gynaecomastia.

He has expert knowledge in Breast Augmentation, Breast Reduction, Gynaecomastia, Abdominoplasty and Facelift.

The particular issues like bat ears or gynaecomastia are taken care at these clinics.

This should be taken into account when interpreting the results of hormonal assays and may result in gynaecomastia.

Gynaecomastia may not resolve spontaneously following cessation of therapy, particularly after prolonged treatment.

Adverse events that may suggest increase in prolactin levels (e. g., amenorrhoea, galactorrhoea, gynaecomastia) were reported overall in 2% of subjects.

Once gynaecomastia is diagnosed cosmetic surgery is often needed to correct the problem.

They can also cause you to develop gynaecomastia often requiring alternative treatment.

Atherosclerosis of testicular artery impairs testosterone production and cause 'senile' gynaecomastia.

Young men are the most likely to develop breast cancer because of the wide use of female hormones and metabolisers, which spark off gynaecomastia which often goes untreated.

The most common side effects with Lysodren (seen in more than 1 patient in 10) are increased blood levels of liver enzymes, cholesterol and triglycerides (a type of fat), leucopenia (low white blood cell counts), prolonged bleeding time, ataxia (difficulty co-ordinating movements), paraesthesia (abnormal sensations like pins and needles), vertigo (a spinning sensation), sleepiness, mucositis (inflammation of the mucous membranes, such as the lining of the mouth), vomiting, diarrhoea, nausea (feeling sick), epigastric discomfort (discomfort around the stomach), skin rash, myasthenia (muscle weakness), adrenal insufficiency (reduced adrenal gland activity), loss of appetite, asthenia (weakness), gynaecomastia (breast enlargement) and confusion.

Not known (frequency cannot be estimated from the available data) abnormal blood pigment levels: which may change the colour of your skin abnormal development of breasts (gynaecomastia) involuntary muscle spasms after prolonged use, particularly in elderly patients high fever, high blood pressure, convulsions, sweating, production of saliva.

The requested additional analyses of the EPC trial data confirm an increased risk for deaths coded as heart failures (however, with no overall excess risk in the cardiovascular system), an increased risk of urogenital symptoms (including gynaecomastia and breast pain) mainly during the first year of intake, and further indicate the absence of an adverse effect on thromboembolic events during the follow-up (supported by a pattern of events inconsistent with hormonal effects).

Adverse reactions that may suggest increase in prolactin levels (e.g., amenorrhoea, galactorrhoea, menstrual disturbances, gynaecomastia) were reported overall in 9.3% of subjects.

Adverse reactions that may suggest increase in prolactin levels (e.g., amenorrhoea, galactorrhoea, menstrual disturbances, gynaecomastia) were reported overall in 2% of subjects.

Alopecia, altered bowel habits, dyspepsia, dyspnoea, rhinitis, gastritis, gingival hyperplasia, gynaecomastia, hyperglycaemia, impotence, increased urinary frequency, leucopenia, malaise, mood changes, myalgia, peripheral neuropathy, pancreatitis, hepatitis, thrombocytopenia, vasculitis, angioedema and erythema multiforme.

Adults with growth hormone deficiency commonly reported abnormal sensations of tingling, pricking or numbness (paraesthesia), abnormally high levels of blood glucose, excess of lipids (fat) in the blood, sleeplessness, joint disorders, arthrosis (degenerative joint disease), muscle weakness, back pain, breast pain and breast enlargement (gynaecomastia).

Hormonal effects of antipsychotics include hyperprolactinaemia, which may cause galactorrhoea, gynaecomastia and oligomenorrhea or amenorrhoea (see section 4.8).

Gynaecomastia and breast pain have been highlighted (mainly in the 1st year of intake) and can be managed in many patients.

The European Medicines Agency has waived the obligation to submit the results of studies with Arimidex in one or several subsets of the paediatric population in short stature due to growth hormone deficiency (GHD), testotoxicosis, gynaecomastia, and McCune-Albright syndrome.

The MAH also proposed to include a summary of the paediatric studies on gynaecomastia and McCune-Albright syndrome, which had already been approved in a number of countries.